Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of March 2026. The report details a corporate governance event regarding a Special General Meeting of Shareholders convened on March 3, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding a shareholder meeting and contains no financial performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The only material event noted is the procedural adjournment of the Special General Meeting due to a lack of quorum.
Guidance, Outlook, and Management Commentary
Management has announced that the Special General Meeting, originally scheduled for March 3, 2026, was adjourned for one week. The meeting will be reconvened on Tuesday, March 10, 2026, at 3:00 p.m. Israel time at the Company's offices in Ramat Gan, Israel. No financial guidance, risk factors, or unusual items are disclosed in this text.
Key Facts for Investor Verification
- The Special General Meeting of Shareholders was adjourned on March 3, 2026, due to a lack of quorum.
- The reconvened meeting is scheduled for March 10, 2026, at 3:00 p.m. Israel time.
- The meeting location remains the Company's offices at 26 Ben Gurion Street, Ramat Gan, Israel.
- This filing contains no financial results or operational metrics.